GlassScriptPhysician profile
Haseeb Ahmed
NPI 1487917852
$16,223.36
in general payments reported to CMS, 2019-2025
36 companies · $2,706 in 2025
The $2,706 reported for 2025 was more than what 85% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,556 · 2020: $482 · 2021: $391 · 2022: $1,343 · 2023: $1,617 · 2024: $2,129 · 2025: $2,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,318 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,318.01 |
| Education | $133.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $6,439.85 | 2019-2023 | Rebyota |
| Abbvie INC. | $3,127.38 | 2019-2025 | Skyrizi, Rinvoq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $629.35 | 2019-2025 | Xifaxan, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $627.95 | 2019-2025 | Entyvio, Vpriv, Eohilia |
| Pfizer INC. | $615.10 | 2023-2025 | |
| Janssen Biotech, INC. | $556.18 | 2019-2025 | Tremfya, Simponi, Stelara |
| Regeneron Healthcare Solutions, INC. | $404.62 | 2022-2025 | Dupixent |
| Genzyme Corporation | $383.62 | 2022-2025 | |
| Qol Medical, LLC | $291.70 | 2019-2025 | Sucraid |
| Ardelyx, INC. | $287.14 | 2023-2025 | Ibsrela |
| Madrigal Pharmaceuticals | $278.84 | 2024-2025 | Resmetirom, Rezdiffra |
| Lilly USA, LLC | $242.69 | 2025 | Omvoh, Mounjaro, Zepbound |
| Novo Nordisk INC | $241.16 | 2019-2025 | Wegovy |
| Celltrion USA INC. | $219.63 | 2024-2025 | Zymfentra, Vegzelma |
| Redhill Biopharma INC. | $203.09 | 2020-2024 | Talicia |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $197.15 | 2019-2020 | |
| Braintree Laboratories, INC. | $193.01 | 2022-2024 | Sutab, Suflave |
| Exact Sciences Corporation | $174.38 | 2023-2024 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $141.04 | 2019-2024 | Linzess |
| Celgene Corporation | $125.66 | 2021-2024 | Zeposia |
| Janssen Scientific Affairs, LLC | $125.00 | 2020 | |
| Phathom Pharmaceuticals, INC. | $107.95 | 2024-2025 | Voquezna |
| Intercept Pharmaceuticals, INC. | $100.52 | 2020-2023 | Ocaliva |
| Aimmune Therapeutics, INC. | $77.24 | 2023-2025 | Vowst |
| Evoke Pharma, INC. | $62.88 | 2021-2022 | |
| Vivus LLC | $52.00 | 2019 | |
| Shionogi INC | $49.36 | 2019 | |
| Concordia Pharmaceuticals INC. | $47.93 | 2019 | |
| Daiichi Sankyo INC. | $44.72 | 2019 | |
| Olympus America INC. | $34.46 | 2023-2024 | Water Container For Model Hpu-20, Single Use Biopsy Valve (Sterile) |
| Nestle Healthcare Nutrition INC. | $28.36 | 2023 | |
| Merck Sharp & Dohme LLC | $25.31 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.99 | 2021 | |
| Sandoz INC. | $24.64 | 2023 | Hyrimoz |
| Ipsen Biopharmaceuticals, INC | $23.88 | 2025 | Iqirvo |
| Mirum Pharmaceuticals, INC. | $14.58 | 2025 | Livmarli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haseeb Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.